Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E36.43 EPS (ttm)6.68 Insider Own11.50% Shs Outstand908.80M Perf Week3.87%
Market Cap227.84B Forward P/E28.32 EPS next Y8.59 Insider Trans-1.58% Shs Float857.10M Perf Month4.40%
Income6.09B PEG2.47 EPS next Q1.89 Inst Own84.50% Short Float0.73% Perf Quarter29.91%
Sales25.49B P/S8.94 EPS this Y36.90% Inst Trans0.98% Short Ratio1.82 Perf Half Y14.53%
Book/sh7.59 P/B32.04 EPS next Y8.77% ROA13.60% Target Price231.78 Perf Year52.44%
Cash/sh3.26 P/C74.67 EPS next 5Y14.76% ROE113.60% 52W Range129.21 - 244.55 Perf YTD44.05%
Dividend3.40 P/FCF63.39 EPS past 5Y24.60% ROI22.60% 52W High-0.55% Beta0.25
Dividend %1.40% Quick Ratio1.10 Sales past 5Y4.20% Gross Margin75.90% 52W Low88.23% ATR4.17
Employees35000 Current Ratio1.40 Sales Q/Q16.10% Oper. Margin22.10% RSI (14)68.93 Volatility1.66% 1.49%
OptionableYes Debt/Eq2.35 EPS Q/Q-7.00% Profit Margin23.90% Rel Volume0.78 Prev Close244.15
ShortableYes LT Debt/Eq2.35 EarningsAug 03 BMO Payout45.70% Avg Volume3.43M Price243.21
Recom2.10 SMA203.79% SMA5010.57% SMA20030.30% Volume2,671,997 Change-0.39%
Jun-24-21Reiterated Cantor Fitzgerald Overweight $245 → $300
Jan-19-21Upgrade Mizuho Neutral → Buy $164 → $222
Dec-10-20Upgrade Wolfe Research Peer Perform → Outperform $147 → $183
Nov-10-20Resumed Bernstein Mkt Perform $150
Sep-29-20Initiated Berenberg Hold $144
Sep-03-20Upgrade Morgan Stanley Equal-Weight → Overweight $176
Jun-16-20Upgrade Guggenheim Neutral → Buy
Apr-21-20Downgrade UBS Buy → Neutral $157 → $158
Apr-09-20Downgrade Morgan Stanley Overweight → Equal-Weight $148
Feb-06-20Initiated Mizuho Neutral
Dec-18-19Upgrade Morgan Stanley Equal-Weight → Overweight $116 → $150
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Jul-24-21 06:37AM  
Jul-23-21 08:01AM  
Jul-22-21 10:00AM  
05:55AM  
Jul-20-21 02:53PM  
08:38AM  
Jul-19-21 01:45PM  
11:14AM  
10:31AM  
Jul-17-21 11:02AM  
07:37AM  
Jul-16-21 01:57PM  
11:48AM  
10:00AM  
07:18AM  
Jul-15-21 10:43AM  
10:00AM  
Jul-14-21 12:57PM  
08:19AM  
07:00AM  
06:45AM  
Jul-12-21 09:29PM  
Jul-09-21 10:45AM  
08:10AM  
06:31AM  
Jul-08-21 04:19PM  
11:40AM  
09:13AM  
Jul-07-21 08:39AM  
06:27AM  
Jul-06-21 04:47PM  
02:18PM  
11:18AM  
06:25AM  
Jul-03-21 06:04AM  
Jul-02-21 07:05AM  
Jul-01-21 09:17AM  
Jun-30-21 07:32AM  
06:43AM  
Jun-29-21 04:27PM  
03:28PM  
03:11PM  
02:58PM  
02:42PM  
01:01PM  
09:04AM  
Jun-28-21 01:15PM  
03:40AM  
Jun-26-21 04:15PM  
01:47PM  
Jun-25-21 04:24PM  
01:53PM  
11:40AM  
11:30AM  
08:16AM  
04:46AM  
Jun-24-21 07:26PM  
05:25PM  
04:16PM  
04:16PM  
04:00PM  
02:59PM  
02:50PM  
11:57AM  
11:54AM  
11:42AM  
11:37AM  
10:28AM  
10:20AM  
10:00AM  
09:06AM  
09:02AM  
08:37AM  
08:10AM  
08:00AM  
07:36AM  
06:59AM  
06:45AM  
05:28AM  
04:41AM  
04:08AM  
Jun-23-21 04:17AM  
Jun-22-21 07:01AM  
06:58AM  
06:20AM  
Jun-19-21 11:03AM  
Jun-18-21 02:00PM  
10:12AM  
09:18AM  
Jun-17-21 05:50PM  
11:00AM  
09:55AM  
09:40AM  
08:00AM  
06:00AM  
06:00AM  
Jun-16-21 04:00PM  
10:26AM  
09:57AM  
Jun-15-21 02:31PM  
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceuticals worldwide. It offers Baqsimi for severe hypoglycemia; Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500, and Lyumjev for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company also provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+ and HER2- metastatic breast cancer. In addition, it offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Further, the company Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; Reyvow for migraine; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Additionally, it Bamlanivimab and etesevimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. Eli Lilly and Company has collaborations with Incyte Corporation; Pfizer Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; and MiNA Therapeutics Limited. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerJul 21Sale237.0086,11120,408,307108,762,100Jul 22 10:47 AM
LILLY ENDOWMENT INC10% OwnerJul 20Sale237.0615,6103,700,429108,848,211Jul 21 11:12 AM
LILLY ENDOWMENT INC10% OwnerJul 14Sale237.0210,7802,555,119108,863,821Jul 15 02:03 PM
LILLY ENDOWMENT INC10% OwnerJul 12Sale237.093,238767,694108,874,601Jul 13 03:08 PM
LILLY ENDOWMENT INC10% OwnerJul 09Sale237.39109,26125,937,091108,877,839Jul 12 12:58 PM
LILLY ENDOWMENT INC10% OwnerJul 06Sale235.09210,00049,369,047108,987,100Jul 07 09:17 AM
LILLY ENDOWMENT INC10% OwnerJul 02Sale232.94202,10247,077,749109,197,100Jul 06 01:05 PM
LILLY ENDOWMENT INC10% OwnerJun 24Sale237.5112,8983,063,401109,399,202Jun 25 01:16 PM
LILLY ENDOWMENT INC10% OwnerJun 10Sale233.63240,00056,072,352109,412,100Jun 11 10:35 AM
LILLY ENDOWMENT INC10% OwnerJun 09Sale224.93220,00049,484,263109,652,100Jun 10 03:35 PM
LILLY ENDOWMENT INC10% OwnerJun 07Sale224.72230,00051,685,008109,872,100Jun 08 03:16 PM
LILLY ENDOWMENT INC10% OwnerMay 24Sale202.277,3291,482,405110,102,100May 25 10:39 AM
LILLY ENDOWMENT INC10% OwnerMay 21Sale200.5892,74018,602,006110,109,429May 24 11:15 AM
LILLY ENDOWMENT INC10% OwnerMay 20Sale200.4899,93120,033,767110,202,169May 21 12:57 PM
TAI JACKSON PDirectorApr 30Buy182.841,366249,75961,195May 03 07:01 PM
Zakrowski Donald AChief Accounting OfficerApr 28Sale181.383,000544,1405,987Apr 29 08:31 PM
LILLY ENDOWMENT INC10% OwnerMar 09Sale209.7959,95912,579,032110,302,100Mar 10 02:59 PM
LILLY ENDOWMENT INC10% OwnerMar 08Sale209.69125,28426,271,092110,362,059Mar 09 12:26 PM
Hakim AnatSVP, GC & SecretaryMar 01Option Exercise0.007,92807,928Mar 03 05:19 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.005,445027,425Feb 03 06:29 PM
Shah Aarti S.SVP & CIDOFeb 01Option Exercise0.006,282023,369Feb 03 07:02 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0075,3870343,639Feb 03 06:57 PM
Smiley Joshua LSVP and CFOFeb 01Option Exercise0.0019,266060,702Feb 03 08:22 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0016,754035,400Feb 03 07:26 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Feb 01Option Exercise0.006,282010,592Feb 03 06:51 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.0012,146056,919Feb 03 06:43 PM
Norton JohnaSenior VP, Global QualityFeb 01Option Exercise0.003,435020,953Feb 03 06:38 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0015,0780115,289Feb 03 06:33 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale190.80215,00041,022,862110,487,343Jan 19 01:04 PM
LILLY ENDOWMENT INC10% OwnerJan 13Sale185.97210,00039,053,064110,702,343Jan 14 11:23 AM
LILLY ENDOWMENT INC10% OwnerJan 11Sale185.49220,00040,807,754110,912,343Jan 12 11:27 AM
Smiley Joshua LSVP and CFOOct 01Option Exercise0.007,947044,918Oct 05 12:19 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMSep 08Sale151.015,000755,05023,580Sep 10 04:25 PM
Mason Michael BSr. VP & Pres., Lilly DiabetesSep 01Option Exercise0.006,244021,279Sep 02 05:04 PM
Fry Stephen FSVP, HR & DiversityAug 17Sale150.647,2041,085,211100,211Aug 18 03:31 PM